41 related articles for article (PubMed ID: 19644041)
1. NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice.
Fotio Y; Mabou Tagne A; Squire E; Lee HL; Phillips CM; Chang K; Ahmed F; Greenberg AS; Villalta SA; Scarfone VM; Spadoni G; Mor M; Piomelli D
Nat Commun; 2024 Feb; 15(1):1705. PubMed ID: 38402219
[TBL] [Abstract][Full Text] [Related]
2. Circulating miR-130 and its target PPAR-γ may be potential biomarkers in patients of coronary artery disease with type 2 diabetes mellitus.
Yuan Y; Peng W; Liu Y; Xu Z
Mol Genet Genomic Med; 2019 Sep; 7(9):e909. PubMed ID: 31368668
[TBL] [Abstract][Full Text] [Related]
3. Vortioxetine exerts anti-inflammatory and immunomodulatory effects on human monocytes/macrophages.
Talmon M; Rossi S; Pastore A; Cattaneo CI; Brunelleschi S; Fresu LG
Br J Pharmacol; 2018 Jan; 175(1):113-124. PubMed ID: 29057467
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in risk factors for coronary artery disease and stroke in men and women aged 45-65 years.
Hochner-Celnikier D; Chajek-Shaul T; Manor O
Heart Asia; 2013; 5(1):229-32. PubMed ID: 27326140
[TBL] [Abstract][Full Text] [Related]
5. Compare the effect of eicosapentaenoic acid and oxidized low-density lipoprotein on the expression of CD36 and peroxisome proliferator-activated receptor gamma.
Babaahmadi Rezaei H; Doosti M; Aminian M; Shabani P
Iran Biomed J; 2013 Apr; 17(2):84-92. PubMed ID: 23567850
[TBL] [Abstract][Full Text] [Related]
6. Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands.
Bardelli C; Amoruso A; Federici Canova D; Fresu L; Balbo P; Neri T; Celi A; Brunelleschi S
Br J Pharmacol; 2012 Feb; 165(3):716-28. PubMed ID: 21745193
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular sex differences influencing microvascular exchange.
Huxley VH; Wang J
Cardiovasc Res; 2010 Jul; 87(2):230-42. PubMed ID: 20495187
[TBL] [Abstract][Full Text] [Related]
8. Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
Zambon A; Gervois P; Pauletto P; Fruchart JC; Staels B
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):977-86. PubMed ID: 16424352
[TBL] [Abstract][Full Text] [Related]
9. Narrowing in on cardiovascular disease: the atheroprotective role of peroxisome proliferator-activated receptor gamma.
Gerry JM; Pascual G
Trends Cardiovasc Med; 2008 Feb; 18(2):39-44. PubMed ID: 18308193
[TBL] [Abstract][Full Text] [Related]
10. Enhanced peroxisome proliferator-activated receptor-gamma expression in monocyte/macrophages from coronary artery disease patients and possible gender differences.
Amoruso A; Bardelli C; Fresu LG; Palma A; Vidali M; Ferrero V; Ribichini F; Vassanelli C; Brunelleschi S
J Pharmacol Exp Ther; 2009 Nov; 331(2):531-8. PubMed ID: 19644041
[TBL] [Abstract][Full Text] [Related]
11. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma in human atherosclerosis.
Sueyoshi S; Mitsumata M; Kusumi Y; Niihashi M; Esumi M; Yamada T; Sakurai I
Pathol Res Pract; 2010 Jul; 206(7):429-38. PubMed ID: 20399568
[TBL] [Abstract][Full Text] [Related]
13. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages.
Kramer PR; Kramer SF; Guan G
Arthritis Rheum; 2004 Jun; 50(6):1967-75. PubMed ID: 15188374
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis.
Culver DA; Barna BP; Raychaudhuri B; Bonfield TL; Abraham S; Malur A; Farver CF; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2004 Jan; 30(1):1-5. PubMed ID: 14512375
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
